Sybil Tasker | CMO
Codagenix Inc.

Sybil Tasker, CMO, Codagenix Inc.

Dr. Tasker is an experienced infectious disease clinician and fellow of the American College of Physicians and the Infectious Diseases Society of America. Prior to joining Codagenix, she served as CMO of Altimmune, where she led the development and clinical testing of influenza and anthrax vaccines. She led development of a therapeutic herpes simplex vaccine at Genocea Biosciences and guided infectious disease product development strategy at two global CROs. Dr. Tasker holds a California medical license and is board certified in both internal medicine and infectious diseases. Dr. Tasker earned an A.B. degree in Biochemistry from Princeton University, an MPH from Johns Hopkins University, and an M.D. degree from Columbia University.


WVIC/WAC Day 2 - Nov 30 @ 11:40

Panel: Research & development goals for influenza vaccines

  • What is the status of the influenza vaccine R&D landscape?
  • What areas of R&D are we focusing on to improve influenza vaccines?
  • Strategic goals for seasonal vs universal flu vaccines
  • Recent milestones achieved and gaps to address
  • What tools do we need to inform policy, and preparedness planning?
  • Pivoting to new manufacturing platforms to ensure faster response – what are the challenges

WVIC/WAC Day 2 - Nov 30 @ 15:30

Codon-deoptimized live attenuated vaccines for respiratory pathogens

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

For sponsorship and exhibition opportunities:
Thomas Hall